Export notification/recordkeeping requirements
This article was originally published in The Rose Sheet
Executive Summary
FDA extends to July 16 the comment period for the proposed rule outlining notification and recordkeeping requirements to persons exporting cosmetics, OTC and human Rx drugs, biologics, devices, animal drugs and food that may not be marketed or sold in the U.S. The notice appeared in the June 17 Federal Register. The proposed rule was published Nov. 24, 1998